Clinical Trials
4 trialsNCT01681433 2022-07-11
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Hoosier Cancer Research Network
Phase 2 Terminated
NCT01780545 2022-07-11
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
Hoosier Cancer Research Network
Phase 2 Completed
NCT01829113 2018-06-08
Spruce
SCRI Development Innovations, LLC
Phase 2 Completed
NCT01844817 2017-05-16
Rainier
SCRI Development Innovations, LLC
Phase 2 Completed